Gan Zhang
30Patents
11h-index
25Co-inventors
75Inventor score
Filing activity: Dec 13, 1999 → Dec 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8513263B2 | Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 77 | Active |
| US8450322B2 | Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors | Emerging Cross-Sectional Technologies | 66 | Active |
| US8865698B2 | Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds | Emerging Cross-Sectional Technologies | 43 | Active |
| US9127013B2 | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds | Emerging Cross-Sectional Technologies | 40 | Active |
| US9676783B2 | Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds | Emerging Cross-Sectional Technologies | 22 | Active |
| US9447104B2 | Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds | Emerging Cross-Sectional Technologies | 20 | Active |
| US6239126A | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives | Chemistry; Metallurgy | 17 | Expired |
| US9796723B2 | Method of treatment using substituted imidazo[1,2b]pyridazine compounds | Emerging Cross-Sectional Technologies | 15 | Active |
| US9795611B2 | Method of treatment using substituted imidazo[1,2b]pyridazine compounds | Emerging Cross-Sectional Technologies | 15 | Active |
| US6638972B2 | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands | Chemistry; Metallurgy | 14 | Expired |
| US9227975B2 | Method of treatment using substituted imidazo[1,2B]pyridazine compounds | Emerging Cross-Sectional Technologies | 12 | Active |
| US10011604B2 | Method of treatment using substituted imidazo[1,2b]pyridazine compounds | Emerging Cross-Sectional Technologies | 9 | Active |
| US10047097B2 | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds | Emerging Cross-Sectional Technologies | 9 | Active |
| US6306859A | N-substituted imide derivatives with serotonergic activity | Chemistry; Metallurgy | 9 | Expired |
| US10005783B2 | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds | Emerging Cross-Sectional Technologies | 9 | Active |
| US6503928B2 | Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives | Chemistry; Metallurgy | 3 | Expired |
| US6326381A | Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates | Chemistry; Metallurgy | 2 | Expired |
| US10259846B2 | Bouvardin derivatives and therapeutic uses thereof | Human Necessities | 1 | Active |
| US9452215B2 | Bourvadin derivatives and therapeutic uses thereof | Human Necessities | 1 | Active |
| USRE47690E1 | Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof | General | 0 | Active |
| US9840520B2 | Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11345725B2 | Bis-thioether stapled peptides as inhibitors of PRC2 function | Chemistry; Metallurgy | 0 | Active |
| US11339150B2 | Benzimidazole compounds as HDAC6 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11267818B2 | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds | Emerging Cross-Sectional Technologies | 0 | Active |
| US9422340B2 | Macrocyclic compounds useful as inhibitors of histone deacetylases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.